Skip to content

A randomized, placebo-controlled, double-blind clinical study of Yiqi Tongmi Formula in the treatment of functional constipation of Qi deficiency type

A randomized, placebo-controlled, double-blind clinical study of Yiqi Tongmi Formula in the treatment of functional constipation of Qi deficiency type

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078206
Enrollment
Unknown
Registered
2023-11-30
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation

Interventions

Test group:Yiqi Tongmi Formula
Control Group:Yiqi Tongmi Formula Simulator

Sponsors

Dongguan Hospital of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 Accord with the diagnostic standard of Chinese and Western medicine for functional constipation; 2Participants agreed to participate in the study, and signed the informed consent; 3Ages between 18 and 75 years old (including 18 and 75 years old) . The patients had normal cognitive function and no dyslexia, and could actively cooperate with the investigation.

Exclusion criteria

Exclusion criteria: 1Did not meet the diagnostic criteria of Chinese and Western medicine for functional constipation; 2 At the same time complicated with serious heart, lung, mental diseases and other basic diseases, or combined with Parkinson's disease, diabetes, cerebral infarction, psychosis and other neurological, mental, endocrine and metabolic system diseases may cause constipation or constipation caused by taking related drugs; 3 Patients with abdominal surgery or constipation due to intestinal stricture caused by intestinal organic diseases such as inflammatory bowel disease, tumors, and intestinal tuberculosis; Defecation disorder caused by anal disease or constipation caused by other systemic organic disease or drug factors; 4 Women who are preparing for pregnancy or are pregnant or lactating; 5Allergic constitution or known components of the drug allergy; Unwilling to accept research measures or other reasons can not cooperate.

Design outcomes

Primary

MeasureTime frame
AR response;

Secondary

MeasureTime frame
The degree of remission of the disease;Improvement in quality of life;Effect of TCM syndrome;Degree of depression and anxiety;

Countries

China

Contacts

Public ContactLiang Danhong

Dongguan Hospital of traditional Chinese medicine

649122794@qq.com+86 159 9970 1020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026